Myriad Genetics
myriad.com ↗In their words
“This is reinforced by our strong 72 Net Promoter Score, which captures how different external groups from providers to payers score their interactions with Myriad.”
“Our turnaround times, along with the focus we're putting into improving customer experience and supporting our strong Net Promoter Score of 72.”
“Along with high internal engagement, we are honored to have been recently recognized by Time Magazine as one of America's best midsized companies of 2024, and to report a customer net promoter score of 72.”
Disclosed NPS over time
Every Net Promoter Score Myriad Genetics has published, by date.
NPS disclosures (20)
Also in 2025, our healthcare provider Net Promoter Score was 72.5, a level typically regarded as excellent, reflecting our continued focus on and investment in the patient and provider experience.
Since the implementation of this program in 2022, we have consistently maintained a strong NPS above 70, which we believe indicates a high level of user satisfaction and advocacy.
As a testament to the focus and ongoing investments we have made in the patient and provider experience, our healthcare provider Net Promoter Score of 72 as of the most recent reading in July 2024, is a score that is typically regarded as excellent.
Since the implementation of this program in 2022, we have consistently maintained a strong NPS above 70, which we believe indicates a high level of user satisfaction and advocacy.
This is reinforced by our strong 72 Net Promoter Score, which captures how different external groups from providers to payers score their interactions with Myriad.
Myriad Genetics achieved a net promoter score of 72 among current providers across its testing portfolio through July 2024.
Our turnaround times, along with the focus we're putting into improving customer experience and supporting our strong Net Promoter Score of 72.
Along with high internal engagement, we are honored to have been recently recognized by Time Magazine as one of America's best midsized companies of 2024, and to report a customer net promoter score of 72.
Their satisfaction with Myriad Genetics led to NPS or Net Promoter Score of 74 in the first quarter, up from 70 for the full year 2023, a figure that has continued to improve over the past few years.
We have maintained a very healthy score since the implementation of the program in 2022, which gives us a strong benchmark to continue to work against as we strive to improve and innovate.
In addition, 2023 saw an overall improvement in satisfaction amongst our healthcare providers, leading to a Net Promoter Score of 69.8 for the year, which is a testament to the focus and ongoing investments we have made in the patient and provider…
We have maintained a very healthy score since the implementation of the program in 2022, which gives us a strong benchmark to continue to work against as we strive to improve and innovate.
Healthcare providers are among our most important constituents and their satisfaction led to a Net Promoter Score of 70 for 2023 a figure that has improved over the past few years as a testament to the focus on ongoing investments we have made in the…
…in hereditary cancer, pharmacogenomics, and prenatal testing 30+ years of scientific and commercial achievements 69 net promoter score1 ~2,700 employees2 1,000+ scientific publications and counting Market-leading gross margins; healthy balance sheet…
Our Net Promoter Scores are strong at 69%, provider retention is up to 70%, turnaround times are down to just 6.3 days and we've added 5,000 new ordering providers to the franchise this quarter.
Our Net Promoter Score among providers remain strong between 63% and 84%. We also announced in Q1 that we have started sharing data with ClinVar.
…growth even further with improved operational efficiencies, like 15% reduction in turnaround times for our oncology tests compared to Q1 of last year, along with a Net Promoter Score of 73% amongst oncology providers and a fully equipped sales force.
…Develop and launch program to serve additional myRisk patients; define and align customer service organization; improve external net promoter score; restructure international organization and better align central functions to the U.S. enterprise…
Everything from improving our customer service as measured by our net promoter scores to the faster turnaround times that providers depend on, we are listening to customers and taking action to make it easier to do business with us.
The test has strong brand loyalty and a 76-point Net Promoter Score. It is the best-selling prenatal DNA test on Amazon ® and the top searched gender test on Google ® with more than 9,000 reviews and a 4.5 star average rating.
Retention disclosures (0)
No retention figures yet.
Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.